Molecular Cytogenetics Market Size Is Projected To Reach $3.8 Billion By 2025: Grand View Research, Inc.

Grand View Research, Inc. – Market Research And Consulting.
According to report published by Grand View Research, the global molecular cytogenetics market size is expected to reach USD 3. 8 billion by 2025. Growing requirement for advanced medical tools and techniques for comprehensive understanding of chronic diseases at genomic level is anticipated to propel demand for molecular cytogenetics.

According to a report by Grand View Research, Inc., global molecular cytogenetics market is anticipated to value USD 3. 8 billion by 2025. Growing requirement for advanced medical tools and techniques for comprehensive understanding of chronic diseases at genomic level is anticipated to propel demand for molecular cytogenetics. Conventionally, cytogenetic analysis was limited to investigation of cellular aspects covering detection of aberrations and study regarding chromosomal structure in heredity conditions. Molecular cytogenetics is likely to accelerate study of chromosomal changes involved in disease pathogenesis, nature of inherited syndromes, and three dimensional organization of human genome.  

Rising cases of chronic diseases such as cancer is likely to influence demand for advanced cytogenetic techniques to understand disease causing mechanism at genomic and cellular level.

Growing awareness and adoption of genetic tests for disease prognosis to support designing of treatment regimens for widespread chromosomal abnormalities can influence growth of market. Rising incorporation of high throughput sequencers in cytogenetic analysis is anticipated to propel growth of market during the forecast period (2014 to 2025).

The molecular cytogenetics market can be segregated on the basis of product, application, end-use, technology, and region. Based on product, the market can be categorized on the basis of consumables, instruments, and software & services.

Full Research Report On Molecular Cytogenetics Market Analysis: https://www.grandviewresearch.com/industry-analysis/molecular-cytogenetics-market

Japan molecular cytogenetics market, by technology, 2014 - 2025 (USD Million)

Based on application, the market can be classified into oncology, genetic disorders, personalized medicine, and other applications. Oncology is expected to emerge as largest application segment during the forecast period attributed to increasing use of molecular cytogenetic technique for in-depth cancer studies.

In addition, personalized medicine segment can also contribute well for market share owing to increasing use of molecular cytogenetic techniques in this field. Numerous applications of molecular cytogenetic analysis in cytogenomics, cytoproteomics, drug discovery and development, and biomarker discovery can influence market growth during the forecast period.

Based on end-use, the market can be segmented into hospitals & pathology laboratories, academic research institutes, pharmaceutical & biotechnology companies, clinical & research laboratories, and other end-use. In 2016, clinical and research laboratories are likely to dominate attributed to rising implementation of cytogenetic techniques in clinical laboratories. Ongoing research related to chromosomal diseases can spur growth.

Similarly, rising demand for targeted therapies can ask for implementation of molecular genetics in pharmaceutical and biotech companies. This, in turn, can fuel growth of segment during the forecast period.

View More Reports Of This Category By Grand View Research At: https://www.grandviewresearch.com/industry/biotechnology

Global molecular cytogenetics market revenue, by region, 2016 (%)

Based on technology, the market can be divided into fluorescence in situ hybridization (FISH), immunohistochemistry, comparative genomic hybridization (CGH), and karyotyping. CGH and FISH segments are likely to grow at substantial rate owing to increasing adoption of these techniques in several applications such as research activities, diagnostics, and medicine development. CGH is likely to dominate other techniques attributed to its essential role in comprehensive cancer studies. In addition, high-resolution offered by array-based CGH can also contribute well for market growth. Array based CGH can address limitations of standard CGH in terms of resolution and labor requirement. Moreover, it can also reduce need for metaphase chromosomes that can result in enhanced resolution.

Regional segmentation includes North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. In 2016, North America dominated the market and accounted for largest market share. High prevalence of majority entities in the region. In addition, presence of supportive regulatory authorities for regulating genetic tests is likely to influence growth of market in this region.

In Asia Pacific, the market is expected to witness significant growth during the forecast period. Continual GDP growth of countries such as India and China is likely to increase purchasing power of consumers and drive market growth. In addition, ongoing workshops in the region related to current trends and developments in human genetics and disease management can fuel growth of market. These workshops are likely to spread awareness regarding importance of advanced diagnostics and therapies among population. This, in turn, can influence market growth in this region.

Some of the leading companies offering molecular cytogenetics are MetaSystems, Oxford Gene Technology, Quest Diagnostics Incorporated, Applied Spectral Imaging, and CytoTest. Most companies are likely to invest in development of advanced products owing to rising demand for cytogenetic analysis. In addition, companies can also get engaged in mutually beneficial partnerships with research institutes and laboratories to boost revenue generation.

Explore the BI enabled intuitive market research database, The Grand Library, by Grand View Research, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com

Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:28 2nd Street, Suite 3036
City: San Francisco
State: California
Country: United States
Website: www.grandviewresearch.com/industry-analysis/molecular-cytogenetics-market